Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Japan is breaking ground in areas the rest of the world will soon be addressing: old age, cancer, neuroscience. The tiny weapon of choice to defeat these diverse threats is nanomedicine. Japan has pumped millions into pursuing the dream of invisible devices, working from within to detect, diagnose and treat. It’s a strategy on the cusp of reaping significant rewards. Multidisciplinary teams are designing micelles coated in compounds to ensure their safe passage to the right areas of the body to deliver drugs where and when they are needed. The results are nothing short of remarkable.
This advertisement feature is produced by Nature Research Custom Media in partnership with The Center of Open Innovation Network for Smart Health (COINS). The advertiser retains responsibility for content. About this content.
Japan’s Braizon Therapeutics Inc has found a cunning way to get pharmaceuticals past the blood-brain barrier by using nanotechnology to piggyback aboard glucose transporters.